These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Maintenance fluconazole therapy for recurrent vulvovaginal candidiasis. Sobel JD, Wiesenfeld HC, Martens M, Danna P, Hooton TM, Rompalo A, Sperling M, Livengood C, Horowitz B, Von Thron J, Edwards L, Panzer H, Chu TC. N Engl J Med; 2004 Aug 26; 351(9):876-83. PubMed ID: 15329425 [Abstract] [Full Text] [Related]
3. [Treatment of recurrent vulvovaginal candidosis with mycosyst (fluconazole)]. Pekhlivanov B, Amaliev I, Ivancheva Kh, Zisova L. Akush Ginekol (Sofiia); 2005 Aug 26; 44 Suppl 2():25-7. PubMed ID: 16028400 [Abstract] [Full Text] [Related]
4. Individualized decreasing-dose maintenance fluconazole regimen for recurrent vulvovaginal candidiasis (ReCiDiF trial). Donders G, Bellen G, Byttebier G, Verguts L, Hinoul P, Walckiers R, Stalpaert M, Vereecken A, Van Eldere J. Am J Obstet Gynecol; 2008 Dec 26; 199(6):613.e1-9. PubMed ID: 18976735 [Abstract] [Full Text] [Related]
5. Prevalence of Candida glabrata and its response to boric acid vaginal suppositories in comparison with oral fluconazole in patients with diabetes and vulvovaginal candidiasis. Ray D, Goswami R, Banerjee U, Dadhwal V, Goswami D, Mandal P, Sreenivas V, Kochupillai N. Diabetes Care; 2007 Feb 26; 30(2):312-7. PubMed ID: 17259500 [Abstract] [Full Text] [Related]
6. Single dose oral fluconazole vs intravaginal terconazole in treatment of Candida vaginitis. Comparison and pilot study. Slavin MB, Benrubi GI, Parker R, Griffin CR, Magee MJ. J Fla Med Assoc; 1992 Oct 26; 79(10):693-6. PubMed ID: 1460451 [Abstract] [Full Text] [Related]
7. Reduced fluconazole susceptibility of Candida albicans isolates in women with recurrent vulvovaginal candidiasis: effects of long-term fluconazole therapy. Shahid Z, Sobel JD. Diagn Microbiol Infect Dis; 2009 Jul 26; 64(3):354-6. PubMed ID: 19501794 [Abstract] [Full Text] [Related]
8. [Treatment of chronic recurrent vulvovaginal candidiasis with fluconazole (fungolon--Actavis)]. Borisov I, Kolarov G, Bobcheva S, Ivanova A. Akush Ginekol (Sofiia); 2005 Jul 26; 44 Suppl 2():17-20. PubMed ID: 16028398 [Abstract] [Full Text] [Related]
10. Single-dose fluconazole versus standard 2-week therapy for oropharyngeal candidiasis in HIV-infected patients: a randomized, double-blind, double-dummy trial. Hamza OJ, Matee MI, Brüggemann RJ, Moshi MJ, Simon EN, Mugusi F, Mikx FH, van der Lee HA, Verweij PE, van der Ven AJ. Clin Infect Dis; 2008 Nov 15; 47(10):1270-6. PubMed ID: 18840077 [Abstract] [Full Text] [Related]
12. [Comparative study of itraconazole and fluconazole therapy in vaginal candidosis]. Vacheva-Dobrevski R, Kovachev S, Nacheva A, Stoev S, Vasilev N. Akush Ginekol (Sofiia); 2004 Nov 15; 43(1):20-3. PubMed ID: 15168649 [Abstract] [Full Text] [Related]
13. In vitro fluconazole and nystatin susceptibility and clinical outcome in complicated vulvovaginal candidosis. Fan SR, Liu XP. Mycoses; 2011 Nov 15; 54(6):501-5. PubMed ID: 20406393 [Abstract] [Full Text] [Related]
15. A clinical multicenter study comparing efficacy and tolerability of topical combination therapy with clotrimazole (Canesten, two formats) with oral single dose fluconazole (Diflucan) in vulvovaginal mycoses. Mendling W, Krauss C, Fladung B. Mycoses; 2004 Apr 15; 47(3-4):136-42. PubMed ID: 15078430 [Abstract] [Full Text] [Related]
16. Clinical resistance of recurrent Candida albicans vulvovaginitis to fluconazole in the presence and absence of in vitro resistance. MacNeill C, Weisz J, Carey JC. J Reprod Med; 2003 Feb 15; 48(2):63-8. PubMed ID: 12621787 [Abstract] [Full Text] [Related]
17. Vulvovaginal candidiasis from non-albicans species: retrospective study of recurrence rate after fluconazole therapy. Ventolini G, Baggish MS, Walsh PM. J Reprod Med; 2006 Jun 15; 51(6):475-8. PubMed ID: 16846086 [Abstract] [Full Text] [Related]